In this dynamic panel-type webinar, the expert speakers will explore how to speed drug development and improve return on investment (ROI) by adopting a “3-D” approach to trials focusing on design, diversity and digitalization.
Oncology trials present unique challenges and will be the focal point for this discussion, but the key insights the speakers will cover are applicable to a wide range of therapeutic areas. Therefore, attendance is recommended across all therapeutic areas, ranging from cardiovascular to neuroscience to rare disease and, in fact, any enrollment-challenged indications.
The need to improve geographical, racial, ethnic and other forms of diversity and inclusion in trials — including new legislation and regulatory guidance documents to spur adoption of diverse trials — has been at the forefront of the industry for several years.
Read more...
With so many recent advances in the application of “big data” strategies and artificial intelligence to trial design and execution, the speakers will discuss concrete ways in which these novel approaches have impacted trials and pipelines. With the perspective of a leading oncology CRO, the speakers will review case studies and aggregate insights with an eye toward improving trial outcomes and performance against key performance indicators (KPIs) by working within an ecosystem where the CRO, investigator sites, patient advocacy groups and industry-leading partners all contribute to a shared mission of accelerating getting new treatments to patients in need.
The panel will cover key questions about innovative approaches to keeping your trials on track to meet their timelines and other key performance indicators.
Read Less...
Register for this webinar today to gain insights into innovative approaches to keeping clinical development on track to meet timelines and other KPIs.
- Clinical Trial Design ,
- Inclusion ,
- DCTs ,
- DHT ,
- Rare Diseases/Orphan Drugs ,
- Sites ,
- Decentralized Clinical Trials ,
- AI ,
- Artificial Intelligence ,
- Diversity ,
- Digital Health Technology ,
- Clinical Trials ,
- Therapeutic Areas ,
- Patient Advocacy Groups ,
- Patient Recruitment ,
- Oncology ,
- CRO ,
- Patient-Centricity ,
- Clinical Research ,
- Drug Development ,
- Rare Disease
Speakers
Geoffrey Kannan, PhD, MD, Executive Medical Director, Head of Americas Oncology Therapeutic Area Expertise, Fortrea
Geoffrey Kannan, PhD, MD, is an Executive Medical Director in the Oncology Therapeutic Area, Head of the Americas Oncology Team and Lead for the Pediatric Oncology Medical Science Leadership Center. Dr. Kannan also provides medical and scientific governance to Sponsors, supporting development and execution of oncology clinical trials. Dr. Kannan brings more than 25 years of oncology scientific and medical experience to Fortrea.
Read more...
Read Less...
Brian Dolan, Vice President, Artificial Intelligence and Machine Learning, Fortrea
Brian Dolan is a mathematician, inventor and cyberneticist with decades of experience building enterprise-grade artificial intelligence products. Equally comfortable in product, sales and technology roles, Brian excels at translating complex business problems into tractable mathematical solutions. He leverages 10 years of CXO experience leading multiple companies from seed to growth stage, including Yahoo, Greenplum and Deep6 AI and others. Before joining Fortrea, he most recently served as the CEO of Verdant AI.
Message Presenter
Alicia M. Baker McDowell, DRSc, MS, EMBA, Head of Regulatory Strategy and Product Development Consulting, Fortrea
Alicia Baker McDowell is Head of Regulatory Strategy and Product Development Consulting at Fortrea based in Southern New Jersey. Alicia has over 28 years of drug development experience, including over 25 years in global regulatory strategy. Alicia has registered products across the globe in over 90 countries and is experienced in direct agency interactions with health authorities, including US FDA, EMA, Health Canada, MHRA, NMPA, PMDA, KFDA, TGA and others.
Her experience spans small molecules, biologics, advanced therapies and devices across multiple therapeutic areas. She is also well versed in rare disease development and expedited development pathways and designations. Recently, she has lead an enterprise wide workstream on Diversity Plans at Fortrea transitioning into a strategic offering for clients with the team engaged in writing over 30 diversity plans.
Read more...
Alicia has a BS in Biology from St. Joseph’s University, a MS in Regulatory Affairs/Quality Assurance from Temple University, a MS in Regulatory Science from the University of Southern California, an Executive MBA from Quantic School of Business and Technology and a Doctorate in Regulatory Science from the University of Southern California.
Read Less...
Melissa Harris, Head of Global Patient Recruitment and Engagement, Fortrea
Melissa Harris has 23 years of industry experience dedicated to accelerating patient recruitment from all possible feeds, including site EHRs, AI and data-enabled recruitment channels, digital and online media and community engagement programs. Melissa works to harness the benefits of applying innovative solutions toward successful patient recruitment and retention campaigns while driving health literacy, diversity and inclusion and patient access equity to reduce study burden and facilitate enrollment into everyday life. Melissa heads up Fortrea’s Voice of Patient program to drive patient insights into every step of the drug development paradigm and is a Co-Lead of Fortrea’s Site Advisory Board.
Message Presenter
Clare Campbell-Cooper, Global Head, Digital Health and Innovation, Fortrea
Clare Campbell-Cooper joined Fortrea in February 2020 and serves as its Global Head of Digital Health and Innovation. Clare has over 25 years of industry experience and is a recognized leader within the field of digital health. Clare has a wealth of experience encompassing many disciplines within clinical research and has held management positions within Data Management, Clinical Monitoring, Phase I Operations, Strategy and Planning, Project Management and, most recently, Digital Health.
Read more...
In her role as Global Head of Digital Health and Innovation at Fortrea Clare is helping to change the face of how clinical research is developing. She specialises in strategy development for both internal and external partners. Clare’s special interest lies in the relationship between the caregiver and physician team and how the use of digital technology can augment this.
Read Less...
Who Should Attend?
This webinar will be useful for bio/pharmaceutical and medical device/biotechnology professionals working in the following areas:
- Oncology: Sponsors with a pipeline supporting novel cancer therapeutics
- Rare diseases and other recruitment-limited indications: learn strategies to meet your timelines
- Trial optimization: anyone working on trial design and optimization for the latest models including patient-centric design and artificial intelligence
- Investigator site relations: Investigators and all stakeholders responsible for identifying and working with sites
- Patient recruitment: all clinical trial staff that focus on recruitment and relationships with patient advocacy groups (PAGs)
- Diversity plans: Sponsors looking for guidance and assistance with successfully writing, executing, and tracking plans
- Digital health technology: industry professionals looking to deepen their understanding of changes within the clinical research
What You Will Learn
Attendees will learn about:
- Key lessons in applying novel strategies to boost DEI from real-world examples to support trial designs that will enhance ROI and adherence to KPIs
- The importance of incorporating new data strategies and the impact of artificial intelligence on trial design and execution will be discussed in the form of case studies and insights from around the industry
Xtalks Partner
Fortrea
Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account